Neurocrine Biosciences, Inc. Delays Indiplon Application To Summer 2008

Nov 2 (Reuters) - Neurocrine Biosciences Inc. (NBIX.O: Quote, Profile, Research) on Thursday delayed the re-submission for approval of its experimental sleep drug indiplon to summer 2008.

>>> Discuss This Story

Back to news